IBEX SEC Filings, Sep 8-15, 2026

IBEX Ltd (IBEX) received a Rule 144 notice indicating that affiliate Julie Casteel, through J.P. Morgan Securities LLC, plans to sell up to 17,474 shares of common stock of IBEX. The filing reports an aggregate market value of about $706,064.48 for the planned sale as of September 15, 2026.

The shares to be sold arise from equity compensation, including performance stock units (PSUs) scheduled to vest on February 6, 2026 for 16,000 shares and on June 30, 2026 for 1,604 shares.

IBEX Ltd (IBEX) has a notice of proposed sale under Rule 144 filed on behalf of affiliate Christina Alice Trofimuk O’Connor. The filing covers potential sales of 7,500 shares of common stock, with an aggregate market value of $302,251.82, based on NASDAQ pricing as of September 15, 2026. The notice also lists equity compensation shares from performance stock unit (PSU) vests scheduled in 2025 and 2026 that may become available for sale, with J.P. Morgan Securities LLC acting as agent and attorney-in-fact.

IBEX Ltd (IBEX) has a Form 144 notice stating that officer Inson Paul Joseph may sell up to 2,274 shares of IBEX common stock through RBC Capital Markets LLC on or after September 14, 2026. The shares relate to RSU vestings of 625 shares on July 1, 2025 and 1,649 shares on October 2, 2025. The planned sales are disclosed as being made pursuant to a Rule 10b5-1 trading plan established on December 16, 2025.

IBEX Ltd (IBEX) received a Form 144 notice that officer David Martin Afdahl may sell shares of IBEX common stock under Rule 144. The notice covers a proposed sale of 10,819 shares through RBC Capital Markets LLC on NASDAQ, with an aggregate market value of $433,482.00 as reflected in the form.

The securities to be sold were acquired via a restricted stock award vesting on December 31, 2018. The filer also reports that, during the prior three months, 17,500 IBEX shares were sold for an aggregate consideration of $649,008.00. The filing states the planned sale is made pursuant to a Rule 10b5-1 plan established June 8, 2026.

IBEX Ltd (IBEX) received a Form 144/A notice reporting a planned resale of restricted common shares under Rule 144 for the account of officer David Martin Afdahl. The filing covers up to 17,500 common shares to be sold through RBC Capital Markets LLC on NASDAQ, with an aggregate market value of $649,008.00 based on the stated market price.

The shares to be sold were acquired from the issuer upon the vesting of restricted stock awards on December 31, 2018. The amendment notes it relates to the acquisition of shares that were sold and previously filed for a transaction dated September 8, 2026.

IBEX Ltd (IBEX) reported that its Chief Operating Officer, David Martin Afdahl, sold common shares in an open-market transaction. On September 8, 2026, he sold 17,500 common shares at a weighted average price of $37.0862 per share, pursuant to a Rule 10b5-1 trading plan dated June 8, 2026. Following this sale, he directly owns 140,006 common shares of IBEX Ltd.

IBEX Ltd (IBEX) reports solid growth for the year ended June 30, 2026, as its AI‑enabled customer experience and BPO platform expanded with approximately 140 clients and about 35,000 employees across 30 delivery centers in the U.S., Philippines, Jamaica, Nicaragua, Pakistan and Honduras.

Revenue rose to $644.1 million with income from operations of $55.0 million and net income of $46.3 million, while diluted EPS reached $3.13. Cash from operations strengthened to $59.0 million, supporting capital expenditures of $27.8 million and ongoing investments in the Wave iX AI platform and global sites. The balance sheet shows $32.6 million of cash, minimal debt (about $1.7 million of finance lease obligations), and stockholders’ equity of $170.2 million, alongside significant operating lease and purchase commitments totaling $90.2 million.

Management highlights a strategy centered on AI‑powered CX (“BPO 3.0”), a “land and expand” client model, and a largely offshore/nearshore footprint where 97% of on‑site capacity resides. Key risks include dependence on major clients, exposure to foreign currency movements (notably Philippine Peso, Jamaican Dollar and Pakistani Rupee), extensive lease obligations, potential future Bermuda corporate taxation once revenue exceeds €750 million, and possible dilution from a warrant granted to Amazon.

IBEX Ltd (IBEX) extended and expanded its credit facilities and reported record fiscal 2026 results with guidance for 2027. The U.S. Credit Agreement maturity was pushed to the earlier of October 22, 2029 or the Amended UAE Credit Agreement’s maturity, with a $25 million secured revolving facility subject to a 0.20% closing fee and a 0.30% annual commitment fee on the unused portion. In the UAE, Ibex Global FZ-LLC extended its facilities to October 22, 2029, kept a committed $50 million post-shipment seller revolving loan and a $50,000 credit card facility, added a $1 million performance bond facility, and granted a security interest over receivables up to $58.9 million.

For fiscal 2026, revenue rose 15.4% to $644.1 million, net income increased to $46.3 million, adjusted EBITDA to $82.4 million, and diluted EPS to $3.13, with free cash flow of $31.2 million and year-end net cash of $30.9 million. Guidance for fiscal 2027 calls for revenue of $700–$715 million and adjusted EBITDA of $90–$94 million, implying high-single to low-double-digit growth.

IBEX Ltd (IBEX) received a notice that company officer David Martin Afdahl plans to sell 17,500 shares of common stock under Rule 144. The planned sale, through RBC Capital Markets LLC, has an indicated aggregate market value of $649,008.00 and references 13,389,116 shares outstanding for this class.

The shares are tied to an ISO exercise dated June 30, 2020 and are to be sold on or after September 8, 2026 on NASDAQ pursuant to a Rule 10b5-1 trading plan established June 8, 2026.